SML3216

Melarsoprol

≥98% (HPLC)

• 同義詞: (2-(4-(4,6-diamino-1,3,5-triazin-2-ylamino)phenyl)-1,3,2-dithiarsolan-4-yl)methanol, 2-(4-melamin-2-ylphenyl)-4-hydroxymethyl-1,3-dithia-2-arsolane, 2-p-(4,6-diamino-s-triazin-2-ylamino)phenyl-4-hydroxymethyl-1,3,2-dithiarsoline, Mel B, Melarsaprol, Melarsen B, RP 3854, p-[(4,6-diamino-s-triazin-2-yl)amino]dithiobenzenearsonous acid 3-hydroxypropylene ester
• 經驗公式（希爾表示法）: C₁₂H₁₅AsN₆OS₂
• CAS號碼: 494-79-1
• 分子量：: 398.34
• MDL號碼: MFCD00866803
• 分類程式碼代碼: 12352107
• NACRES: NA.77

屬性

• 品質等級: 100
• 化驗: ≥98% (HPLC)
• 形狀: powder
• 顏色: white to beige
• 溶解度: DMSO: 2 mg/mL, clear
• 儲存溫度: 2-8°C
• SMILES 字串: NC1=NC(N)=NC(NC2=CC=C(C=C2)[As]3SCC(S3)CO)=N1
• InChI: 1S/C12H15AsN6OS2/c14-10-17-11(15)19-12(18-10)16-8-3-1-7(2-4-8)13-21-6-9(5-20)22-13/h1-4,9,20H,5-6H2,(H5,14,15,16,17,18,19)
• InChI 密鑰: JCYZMTMYPZHVBF-UHFFFAOYSA-N

描述

生化／生理作用

An antiprotozoal (Trypanosoma) drug used in treatment of trypanosomiasis (Chagas disease and West African sleeping sickness);

Melarsoprol is an antiprotozoal (Trypanosoma) drug used in treatment of trypanosomiasis (Chagas disease and West African sleeping sickness). The drug mechanism of action is not well characterized. Melarsoprol is still the only effective drug for chemotherapy of second stage of T. b. rhodesiense sleeping sickness. As other arsenic-containing compounds melarsoprol causes cell apoptosis of myeloma and other cancer cell lines.

安全資訊

• 象形圖: GHS06,GHS09
• 訊號詞: Danger
• 危險聲明: H301 + H331,H410
• 防範說明: P261 - P264 - P271 - P273 - P301 + P310 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable